Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Cells|July 13, 2019
Arrestin Domain Containing 3 Reverses Epithelial to Mesenchymal Transition and Chemo-Resistance of TNBC Cells by Up-Regulating Expression of miR-200bYoung Hwa Soung, Heesung Chung, Cecilia Yan, et al.
Plos One|December 30, 2008
Reduction of Orc6 expression sensitizes human colon cancer cells to 5-fluorouracil and cisplatinElaine J Gavin, Bo Song, Yuan Wang, et al.
BMC Genomics|April 6, 2006
Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancerYaguang Xi, Go Nakajima, John C Schmitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
Regulation of p53 expression in response to 5-fluorouracil in human cancer RKO cellsJingfang Ju, John C Schmitz, Bo Song, et al.
Cancer Translational Medicine|July 28, 2017
Autophagy regulated by miRNAs in colorectal cancer progression and resistanceAndrew Fesler, Hua Liu, Ning Wu, et al.
Molecular Cancer Therapeutics|December 19, 2006
Association of insulin-like growth factor binding protein-3 expression with melanoma progressionYaguang Xi, Go Nakajima, Tray Hamil, et al.
Clinical Colorectal Cancer|September 10, 2013
Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancerHaiyan Zhai, Andrew Fesler, Kristina Schee, et al.
Bioorganic & Medicinal Chemistry|September 25, 2007
Dual-acting agents that possess reversing resistance and anticancer activities: Design, synthesis, MES-SA/Dx5 cell assay, and SAR of Benzyl 1,2,3,5,11,11a-hexahydro-3,3-dimethyl-1-oxo-6H-imidazo[3',4':1,2]pyridin[3,4-b]indol-2-substitutedacetatesJiawang Liu, Guohui Cui, Ming Zhao, et al.
Cancer Genomics & Proteomics|March 17, 2009
Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell lineRebecca A Rowehl, Howard Crawford, Antoine Dufour, et al.
Bioorganic & Medicinal Chemistry|November 27, 2007
Toward the development of chemoprevention agents (III): synthesis and anti-inflammatory activities of a new class of 5-glycylamino-2-substituted-phenyl-1,3-dioxacycloalkanesLanrong Bi, Ming Zhao, Keli Gu, et al.
Pageof 11